“Increasing use of advanced viral clearance techniques”
The increasing use of advanced viral clearance techniques is a significant trend shaping the viral clearance market. As the biopharmaceutical industry continues to develop more complex therapies, especially biologics, gene therapies, and monoclonal antibodies, there is a greater need for highly efficient and reliable viral clearance methods. Advanced techniques, such as high-throughput filtration, chromatography, and virus inactivation technologies, are now commonly employed to ensure the removal of viral contaminants from drug products.
One of the key advancements is the improvement in chromatography techniques, such as size exclusion and ion exchange chromatography, which allow for more precise viral removal during the manufacturing process. These methods are becoming the standard as they offer better scalability, improved yield, and more efficient virus removal. Additionally, advances in filtration technology, including tangential flow filtration and membrane-based systems, have also enhanced viral clearance efficiency.
Virus inactivation technologies, such as ultraviolet light and chemical treatments, are seeing broader adoption due to their ability to eliminate a wide range of viral contaminants. These techniques are increasingly integrated into the production process, improving overall safety and reducing the risk of viral transmission.
